Posts in category Long Ideas


Glu Mobile Inc. (GLUU) Partners with WWE for the Making of New Wrestling Game: Another Tap Sports Baseball Phenomenon Ahead?

Just two days ago, Glu Mobile Inc. (NASDAQ:GLUU) announced it had entered into a multi-year …

Read more

$100 Million Deal That Will Make Snap Inc Great Again?

Yesterday, Snap Inc (NYSE:SNAP) signed a “big” $100 million deal with Time Warner, agreeing to …

Read more

Rosenblatt Confident on Oracle Corporation (ORCL) Heading into the FQ4 Earnings

Oracle Corporation (NYSE:ORCL) is set to deliver its fourth fiscal quarter print for the year …

Read more

Snap Inc (SNAP) Post-IPO Dip Presents Attractive Opportunity for Investors

Snap Inc (NYSE:SNAP) may have been on a trading cloud nine when its initial public …

Read more

Pandora Media Inc (P) Redirects Attention to Fundamentals; Aegis Lowers Price Target

SiriusXM’s $480 million investment into Pandora Media Inc (NYSE:P) obviously ends any takeout speculation. As such, Aegis …

Read more

Analysts Signal Strength in Micron Technology, Inc. (MU) and Apple Inc. (AAPL); Here’s Why

Mizuho and Credit Suisse are providing bullish perspectives on two leaders of the tech-verse: Micron Technology, …

Read more

Analyst Insights: Apple Inc. (AAPL) Makes AI Waves with No-Longer-Secret Project Titan, Tesla Inc (TSLA) Set to Outperform its OEM Competition

Famed Apple Inc. (NASDAQ:AAPL) guru Gene Munster offers a bullish slice of the Apple pie …

Read more

Key Takeaways From William Blair’s Annual Growth Stock Conference: Gilead Sciences, Inc. (GILD), Exelixis, Inc. (EXEL)

William Blair analyst John Sonnier is out highlighting standout insights from his 37th Annual Growth …

Read more

Coherus Biosciences Inc (CHRS) Hits ‘Speed Bump’ for CHS-1701; Maxim Remains Positive

Yesterday, Coherus Biosciences Inc (NASDAQ:CHRS) received a Complete Response Letter (CRL) from the FDA for …

Read more

Rodman & Renshaw Roots for Synergy Pharmaceuticals Inc. (SGYP) Ahead of Promising Commercial Trajectory for Trulance

Last week, Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) excited investors with the news that its drug Trulance, …

Read more